ABRAMS CAPITAL MANAGEMENT, L.P. — NUVATION BIO INC NUVB: Quarterly 13F Position History
ABRAMS CAPITAL MANAGEMENT, L.P. has reported NUVATION BIO INC (NUVB) on 21 13F-HR filings in Pactolio's tracked window, first appearing in Q1 2021. As of Q1 2026, the position is sized at 1,270,504 shares ($5.5M market value, 0.12% of the equity book). Quarter-over-quarter share count change: 2,541,009 (-66.7%) .
- 1,270,504Shares Held (Latest Filing)
- $5.5MReported Market Value (Latest Filing)
- 0.12%Portfolio Weight (% of 13F Equity Book)
- 2,541,009Quarter-over-Quarter Share Change
- -$28.7MQuarter-over-Quarter Value Change
- 3,811,513Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 21 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 1,270,504 | 2,541,009 | -66.7% | $5.5M | 0.12% | $4.29 |
| Q4 2025 | 3,811,513 | 0 | — | $34.2M | 0.60% | $8.96 |
| Q3 2025 | 3,811,513 | 0 | — | $14.1M | 0.23% | $3.70 |
| Q2 2025 | 3,811,513 | 0 | — | $7.4M | 0.12% | $1.95 |
| Q1 2025 | 3,811,513 | 0 | — | $6.7M | 0.12% | $1.76 |
| Q4 2024 | 3,811,513 | 0 | — | $10.1M | 0.16% | $2.66 |
| Q3 2024 | 3,811,513 | 0 | — | $8.7M | 0.14% | $2.29 |
| Q2 2024 | 3,811,513 | 0 | — | $11.1M | 0.22% | $2.92 |
| Q1 2024 | 3,811,513 | 0 | — | $13.9M | 0.43% | $3.64 |
| Q4 2023 | 3,811,513 | 0 | — | $5.8M | 0.18% | $1.51 |
| Q3 2023 | 3,811,513 | 0 | — | $5.1M | 0.17% | $1.34 |
| Q2 2023 | 3,811,513 | 0 | — | $6.9M | 0.20% | $1.80 |
| Q1 2023 | 3,811,513 | 0 | — | $6.3M | 0.20% | $1.66 |
| Q4 2022 | 3,811,513 | 0 | — | $7.3M | 0.26% | $1.92 |
| Q3 2022 | 3,811,513 | 0 | — | $8.5M | 0.25% | $2.24 |
| Q2 2022 | 3,811,513 | 0 | — | $12.3M | 0.33% | $3.24 |
| Q1 2022 | 3,811,513 | 0 | — | $20.0M | 0.47% | $5.26 |
| Q4 2021 | 3,811,513 | 0 | — | $32.4M | 0.71% | $8.50 |
| Q3 2021 | 3,811,513 | 0 | — | $37.9M | 0.83% | $9.94 |
| Q2 2021 | 3,811,513 | 0 | — | $35.5M | 0.79% | $9.31 |
| Q1 2021 | 3,811,513 | — | — | $34.0M | 0.77% | $8.92 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did ABRAMS CAPITAL MANAGEMENT, L.P. first disclose a NUVB position in 13F-HR filings?
ABRAMS CAPITAL MANAGEMENT, L.P. first reported NUVATION BIO INC (NUVB) on its 13F-HR filing for the period ending 2021-03-31 (Q1 2021). The position has appeared on 21 reported quarters within Pactolio's tracked window.
What was ABRAMS CAPITAL MANAGEMENT, L.P.'s most recent quarter-over-quarter share-count change in NUVB?
Between Q4 2025 and Q1 2026, ABRAMS CAPITAL MANAGEMENT, L.P. reduced its NUVB position by 2,541,009 shares (-66.7%), leaving 1,270,504 shares at a market value of $5.5M.
Does the implied price-per-share represent ABRAMS CAPITAL MANAGEMENT, L.P.'s cost basis in NUVB?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.